Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | FFAR4 | Q5NUL3 | 8/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 8/20 | 0.44 |
| ▸ | TACR1 | P25103 | 1/20 | 0.43 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.40 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.40 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.40 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.40 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.40 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.39 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.39 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.39 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.38 |
| ▸ | FABP7 | O15540 | 1/20 | 0.37 |
| ▸ | FABP3 | P05413 | 1/20 | 0.37 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28257363 | 0.94 | DPP4 (0.42) | DPP4KMT2AFFAR4FFAR1TACR1 | |
| SCHEMBL28119035 | 0.82 | MAOA (0.42) | DPP4FFAR4FFAR1PTGER1PTGER4 | |
| SCHEMBL5542038 | 0.81 | DPP4 (0.46) | DPP4KMT2AFFAR4FFAR1FOLH1 | |
| SCHEMBL11406620 | 0.81 | SRC (0.40) | KMT2A | |
| SCHEMBL29074270 | 0.81 | CYP19A1 (0.45) | — | |
| SCHEMBL5541869 | 0.79 | DPP4 (0.43) | DPP4KMT2AFFAR4FFAR1FOLH1 | |
| SCHEMBL27765185 | 0.78 | PTGER4 (0.41) | DPP4KMT2AFFAR4FFAR1FOLH1 | |
| Acetaldehyde SCHEMBL27895815 | 0.78 | DPP4 (0.46) | DPP4KMT2AFFAR4FFAR1TACR1 | |
| SCHEMBL5546291 | 0.78 | DPP4 (0.42) | DPP4KMT2AFFAR4FFAR1FOLH1 | |
| SCHEMBL28096773 | 0.77 | FFAR1 (0.38) | DPP4FFAR4FFAR1TACR1FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116813512-B | Florfenicol hapten as well as preparation method and application thereof | 中国农业大学 | 2023-11-07 | — | — | CN | claimed |
| CN-116813512-A | Florfenicol hapten as well as preparation method and application thereof | 中国农业大学 | 2023-09-29 | — | — | CN | claimed |
| CN-115968258-A | Carbonated beverage, method for producing flavor composition, and method for suppressing foaming of carbonated beverage | 高砂香料工业株式会社 | 2023-04-14 | — | — | CN | claimed |
| CN-111936468-B | Compounds with anticancer activity | 协和麒麟株式会社 | 2024-03-08 | — | — | CN | disclosed |
| CN-113811287-B | Low VOC multi-functional additives for improving waterborne polymer film properties | 朗盛公司 | 2023-11-17 | — | — | CN | disclosed |
| CN-116813512-B | Florfenicol hapten as well as preparation method and application thereof | 中国农业大学 | 2023-11-07 | — | — | CN | disclosed |
| CN-116813512-A | Florfenicol hapten as well as preparation method and application thereof | 中国农业大学 | 2023-09-29 | — | — | CN | disclosed |
| CN-110304989-A | A kind of synthesis technology of 9,9- dialkyl fluorene derivative | 安徽秀朗新材料科技有限公司 | 2019-10-08 | — | — | CN | disclosed |
| CN-109715615-A | Biaryl methyl heterocycles | 蒙特利尔大学 | 2019-05-03 | — | — | CN | disclosed |
| CN-105330541-B | The synthetic method of the alkyl formate of 4 ' halogenated methyl biphenyl 2 | 常州博世伟业生物科技有限公司 | 2017-09-12 | — | — | CN | disclosed |
| CN-103370307-B | Sulfonamide compounds and preparation method thereof and using method | ZAFGEN CORP. (US) | 2016-05-25 | — | — | CN | disclosed |
| EP-2570418-A2 | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles compound | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2013-03-20 | — | — | EP | disclosed |
| EP-1555267-B1 | 2,3-DIHYDRO-6-NITROIMIDAZO[2,1-b]OXAZOLES | OTSUKA PHARMA CO LTD (JP) | 2013-01-16 | — | — | EP | disclosed |
| US-7262212-B2 | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-08-28 | — | — | US | disclosed |
| CN-1261419-C | Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one and use thereof for inhibiting hormone-sensitive lipase | AVENTIS PHARMA DENTSCHLAND GMD (DE) | 2006-06-28 | — | — | CN | disclosed |
| US-20060094767-A1 | 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-05-04 | — | — | US | disclosed |
| EP-1555267-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-07-20 | — | — | EP | disclosed |
| CN-1416424-A | Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one and use thereof for inhibiting hormone-sensitive lipase | AVENTIS PHARMA DENTSCHLAND GMD (DE) | 2003-05-07 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060094767-A1 | 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles | NR2C2, NR4A3, NR4A2 | DPP4 3965/4885KMT2A 4267/4885FFAR4 338/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.